Department of Pharmaceutical Analysis, The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, 350122, PR China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, 350122, PR China.
Department of Pharmaceutical Analysis, The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, 350122, PR China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, 350122, PR China.
Biosens Bioelectron. 2020 Dec 1;169:112555. doi: 10.1016/j.bios.2020.112555. Epub 2020 Sep 1.
Exosomal microRNAs (miRNAs) have been explored as an extremely promising biomarker of liquid biopsy for the diagnosis, treatment and prognosis of diseases such as cancer, in which sensitive and selective detection is significant. Herein, we describe the construction and testing of an electrochemical biosensor for the sensitive detection of exosomal miRNAs. It is based on synthetizing numerous long single-stranded DNAs (ssDNAs), which are produced by dual amplification reactions of target-triggered cyclic strand displacement reaction (TCSDR) and primer exchange DNA amplification reaction (PEDAR). In the first signal amplification step, target miRNAs are captured by the hairpin DNA strands (capture probes, Cp) that are immobilized on electrode. After strand unfolding with target capture, primer probes (Pp) enable to hybridize with Cp. And then target miRNAs were displaced for starting the TCSDR process that enable the introduction of numerous primers in Pp. In the second signal amplification step, the primers associated with PEDAR produce copious amounts of elongated ssDNAs. These ssDNAs absorb abundant quantities of methylene blue (MB) that enables the highly sensitive and label-free detection of exosomal miRNAs. This dual amplification process is characterized by a low limit of detection (LOD) of 3.04 aM. In addition, the electrochemical biosensor exhibits good selectivity for miR-21 detection, and shows benefits of simple operation, low cost, portability. Overall, the electrochemical biosensor provides a promising platform for the early diagnosis and screening of tumor biomarkers and the development of devices for point-of-care testing (POCT).
外泌体 microRNAs(miRNAs)已被探索作为液体活检的极具前景的生物标志物,用于癌症等疾病的诊断、治疗和预后,其中敏感和选择性检测具有重要意义。本文描述了一种用于外泌体 miRNAs 灵敏检测的电化学生物传感器的构建和测试。该传感器基于合成大量长单链 DNA(ssDNA),这些 ssDNA 是通过目标触发的循环链置换反应(TCSDR)和引物交换 DNA 扩增反应(PEDAR)的双重扩增反应产生的。在第一个信号放大步骤中,目标 miRNA 通过固定在电极上的发夹 DNA 链(捕获探针,Cp)捕获。在目标捕获导致链展开后,引物探针(Pp)能够与 Cp 杂交。然后,目标 miRNA 被置换以启动 TCSDR 过程,该过程允许在 Pp 中引入大量引物。在第二个信号放大步骤中,与 PEDAR 相关的引物产生大量伸长的 ssDNA。这些 ssDNA 吸收大量亚甲基蓝(MB),能够实现外泌体 miRNAs 的高灵敏度和无标记检测。该双重放大过程的特点是检测限(LOD)低至 3.04 aM。此外,电化学生物传感器对 miR-21 检测具有良好的选择性,并且具有操作简单、成本低、便携的优点。总的来说,电化学生物传感器为肿瘤生物标志物的早期诊断和筛选以及用于即时检测(POCT)的设备的开发提供了一个有前景的平台。